PetVivo raises $150,000 via unit option

Q: What did PetVivo Holdings (PETV) announce in its latest 8-K filing?

PetVivo reported receiving $150,000 in gross proceeds from a partial exercise of an investor purchase option, bringing total equity raised under a 2026 Unit Offering to $1,150,000. The financing involves Units combining common stock and three-year warrants.

Q: How many Units has PetVivo (PETV) issued and at what price?

PetVivo has issued 1,437,500 Units at a purchase price of $0.80 per Unit. Each Unit consists of one share of common stock and one warrant to buy an additional share, creating both immediate and potential future equity issuance.

Q: What prior payments has PetVivo (PETV) received under this Subscription Agreement?

PetVivo previously received $400,000 on March 13, 2026 and $600,000 on April 15, 2026, tied to earlier installments under the Subscription Agreement. Those payments corresponded to issuances of 500,000 and 750,000 Units, respectively.

PetVivo Holdings, Inc. received gross proceeds of $150,000 on June 8, 2026 from a partial exercise of an investor purchase option under a March 13, 2026 Subscription Agreement, bringing total equity financing in this unit Offering to $1,150,000.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

PetVivo Holdings, Inc. received gross proceeds of $150,000 on June 8, 2026 from a partial exercise of an investor purchase option under a March 13, 2026 Subscription Agreement, bringing total equity financing in this unit Offering to $1,150,000.

The company has now issued 1,437,500 Units at $0.80 per Unit, including 187,500 Units in the latest tranche. Each Unit includes one common share and a warrant to buy one common share at $1.10 per share, exercisable immediately and expiring three years from issuance.

Earlier installments provided $400,000 on March 13, 2026 for 500,000 Units and $600,000 on April 15, 2026 for 750,000 Units. The investor may still purchase up to an additional $1,350,000 of Units, or 1,687,500 Units, through July 15, 2026 on substantially the same terms.

Insights

PetVivo secures $150,000 in new equity, with capacity for more through July 2026.

PetVivo Holdings, Inc. raised an additional $150,000 via a partial exercise of an investor purchase option, lifting total proceeds from this Unit Offering to $1,150,000. Each Unit pairs one common share with a three-year warrant exercisable at $1.10.

The investor previously funded $400,000 and $600,000 installments, and now retains the right to invest up to another $1,350,000 for 1,687,500 Units on similar terms through July 15, 2026. Actual capital raised will depend on how much of this remaining option the investor exercises.

The securities were issued as “restricted securities” under Section 4(a)(2) and Regulation D, which generally limits immediate resale and concentrates near-term flexibility with this accredited investor. Subsequent filings may clarify any warrant exercises and resulting changes in the company’s capital structure.

8-K Event Classification

3 items: 1.01, 3.02, 9.01

3 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

New proceeds: $150,000 Total proceeds to date: $1,150,000 Latest Units issued: 187,500 Units +5 more

8 metrics

New proceeds $150,000 Gross proceeds from partial option exercise on June 8, 2026

Total proceeds to date $1,150,000 Aggregate equity financing under the 2026 Unit Offering

Latest Units issued 187,500 Units Issued at $0.80 per Unit in the June 8, 2026 tranche

Aggregate Units issued 1,437,500 Units Total Units issued under the Offering to date

Unit price $0.80 per Unit Price for each Unit in the Offering

Warrant exercise price $1.10 per share Exercise price for each warrant included in a Unit

Remaining option capacity $1,350,000 Maximum additional investment the investor may make through July 15, 2026

Potential additional Units 1,687,500 Units Maximum additional Units issuable if remaining option fully exercised

Key Terms

Subscription Agreement, accredited investor, Section 4(a)(2), Regulation D, +2 more

6 terms

Subscription Agreement financial

"pursuant to a partial exercise of the investor’s purchase option granted under that certain Subscription Agreement dated March 13, 2026"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

accredited investor financial

"it is an “accredited investor” (as defined in Rule 501(a) of Regulation D under the Securities Act)"

An accredited investor is an individual or entity that meets certain financial criteria, such as having a high income or significant net worth, allowing them to invest in private or less regulated investment opportunities. This status matters because it grants access to investments that are often riskier or less available to the general public, reflecting a higher level of financial knowledge or resources.

Section 4(a)(2) regulatory

"conducted in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933"

Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.

Regulation D regulatory

"and Regulation D promulgated thereunder"

Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

restricted securities regulatory

"constitute “restricted securities” within the meaning of Rule 144 under the Securities Act"

Restricted securities are shares or other investment instruments that come with legal or contractual limits on when and how they can be sold, like stock given to founders or bought in a private offering. Think of them as assets in a locked box that can’t be freely traded until certain conditions — such as a waiting period, company registration, or specific approvals — are met. For investors this matters because restricted securities are less liquid and can affect timing, price, and perceived value when they eventually enter the market.

Rule 144 regulatory

"within the meaning of Rule 144 under the Securities Act"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

What did PetVivo Holdings (PETV) announce in its latest 8-K filing?

PetVivo reported receiving $150,000 in gross proceeds from a partial exercise of an investor purchase option, bringing total equity raised under a 2026 Unit Offering to $1,150,000. The financing involves Units combining common stock and three-year warrants.

How many Units has PetVivo (PETV) issued and at what price?

PetVivo has issued 1,437,500 Units at a purchase price of $0.80 per Unit. Each Unit consists of one share of common stock and one warrant to buy an additional share, creating both immediate and potential future equity issuance.

What are the terms of the warrants in PetVivo’s (PETV) Unit Offering?

Each warrant in the Offering allows the holder to purchase one share of PetVivo common stock at an exercise price of $1.10 per share. The warrants are exercisable immediately upon issuance and expire three years from the date they are issued.

How much additional capital can PetVivo (PETV) still raise under the option?

The investor retains the right to purchase up to an additional $1,350,000 of Units on substantially the same terms. If fully exercised, this would result in issuing up to 1,687,500 more Units before the option’s July 15, 2026 expiration date.

How were PetVivo’s (PETV) securities in this Offering issued under U.S. securities law?

The Offering, including shares and warrants, relied on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation D. The investor is an accredited investor, and the securities are classified as “restricted securities” under Rule 144.

What prior payments has PetVivo (PETV) received under this Subscription Agreement?

PetVivo previously received $400,000 on March 13, 2026 and $600,000 on April 15, 2026, tied to earlier installments under the Subscription Agreement. Those payments corresponded to issuances of 500,000 and 750,000 Units, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/10/2026 - 06:04 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

June 8, 2026

Date of Report (Date of earliest event reported)

PETVIVO HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Nevada

001-40715

99-0363559

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

5151 Edina Industrial Blvd.

Suite 575

Edina, Minnesota

55439

(Address of principal executive offices)

(Zip Code)

(952) 405-6216

Registrant’s telephone number, including area code

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	PETV	OTC Markets Inc. (OTCQX)
Warrants	PETVW	OTC Markets Inc. (OTCID)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01

Entry into a Material Definitive Agreement.

To the extent required, the discussion of the Subscription Agreement set forth in Item 3.02 below is incorporated by reference into this Item 1.01.

Item 3.02

Unregistered Sales of Equity Securities.

On June 8, 2026, PetVivo Holdings, Inc. (the “Company,” “we,” or “us”), received gross proceeds of $150,000 pursuant to a partial exercise of the investor’s purchase option granted under that certain Subscription Agreement dated March 13, 2026 (the “Subscription Agreement”), for an aggregate investment to date of $1,150,000 in equity financing (the “Offering”).

In connection with such partial exercise, the Company issued 187,500 Units at a purchase price of $0.80 per Unit, bringing the aggregate number of Units issued pursuant to the Offering to date to 1,437,500 Units. Each Unit consists of one share of the Company’s common stock and one warrant to purchase one share of the Company’s common stock. Each warrant has an exercise price of $1.10 per share, is exercisable immediately upon issuance, and will expire three (3) years from the date of issuance.

The Company previously received $400,000 of the Offering proceeds on March 13, 2026 and $600,000 of the Offering Proceeds on April 15, 2026. Of the aggregate Units issued in the Offering, 500,000 Units were issued in connection with the $400,000 installment received on March 13, 2026 and 750,000 Units were issued in connection with the $600,000 installment received on April 15, 2026.

Pursuant to the Subscription Agreement, following the current partial exercise, the investor retains the right, but not the obligation, to purchase up to an additional $1,350,000 of Units on substantially the same terms and conditions. If fully exercised, such additional investment would result in the issuance of up to 1,687,500 additional Units. The option remains exercisable through July 15, 2026.

The Offering, including the issuance of shares, the warrants, and the shares of common stock issuable upon exercise of the warrants, was conducted in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Regulation D promulgated thereunder. The investor entered into the Subscription Agreement and represented in writing that it is an “accredited investor” (as defined in Rule 501(a) of Regulation D under the Securities Act), acquired the securities for its own account for investment purposes, and agreed that any subsequent transfer or sale of such securities will be made in compliance with the Securities Act or pursuant to an available exemption therefrom.

The Shares, the Warrants, and the shares of common stock issuable upon exercise of the Warrants constitute “restricted securities” within the meaning of Rule 144 under the Securities Act, and certificates evidencing such securities will bear an appropriate restrictive legend.

The form of Subscription Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K. The foregoing description of the Subscription Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

10.1

Form of Subscription Agreement

104

Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized

	PETVIVO HOLDINGS, INC.

Date: June 10, 2026	By:	/s/ John Lai
	Name:	John Lai
	Title:	Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

6 documents

Agreements & Contracts

EX-10.1 EX-10.1 88.8 KB

PetVivo raises $150,000 via unit option

Rhea-AI Filing Summary

Positive

Negative